[go: up one dir, main page]

ZA961628B - Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases - Google Patents

Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases

Info

Publication number
ZA961628B
ZA961628B ZA961628A ZA961628A ZA961628B ZA 961628 B ZA961628 B ZA 961628B ZA 961628 A ZA961628 A ZA 961628A ZA 961628 A ZA961628 A ZA 961628A ZA 961628 B ZA961628 B ZA 961628B
Authority
ZA
South Africa
Prior art keywords
test kit
drug
dna
diagnostic method
solid phase
Prior art date
Application number
ZA961628A
Other languages
English (en)
Inventor
Eeva-Marjatta Salonen
Original Assignee
Salonen Eeva Marjatta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salonen Eeva Marjatta filed Critical Salonen Eeva Marjatta
Publication of ZA961628B publication Critical patent/ZA961628B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Saccharide Compounds (AREA)
ZA961628A 1995-03-01 1996-02-29 Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases ZA961628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI950962A FI100556B (fi) 1995-03-01 1995-03-01 Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten

Publications (1)

Publication Number Publication Date
ZA961628B true ZA961628B (en) 1996-08-08

Family

ID=8542958

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961628A ZA961628B (en) 1995-03-01 1996-02-29 Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases

Country Status (9)

Country Link
EP (1) EP0812421B1 (de)
AT (1) ATE219580T1 (de)
AU (1) AU720912B2 (de)
DE (1) DE69621915T2 (de)
ES (1) ES2175069T3 (de)
FI (1) FI100556B (de)
NZ (1) NZ301725A (de)
WO (1) WO1996027131A1 (de)
ZA (1) ZA961628B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
WO2001074342A2 (en) * 2000-03-31 2001-10-11 Trustees Of Boston University Use of locally applied dna fragments
US7018798B2 (en) * 1997-08-12 2006-03-28 Embedded Concepts, Llc Nucleic acid antigens embedded in thermoplastic
WO2005025650A1 (de) * 2003-09-12 2005-03-24 Frank Mattner Apherese-vorrichtung
SI24638A (sl) 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
JP7067800B2 (ja) * 2017-04-12 2022-05-16 国立大学法人九州大学 神経障害性疼痛マーカー及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE61670T1 (de) * 1985-06-25 1991-03-15 Progen Biotechnik Gmbh Immuntest zum nachweis von antikoerpern gegen dns.
AU1070588A (en) * 1987-01-30 1988-08-04 Diagnostic Products Corporation Measuring anti-dna antibodies
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity

Also Published As

Publication number Publication date
ATE219580T1 (de) 2002-07-15
AU720912B2 (en) 2000-06-15
EP0812421A1 (de) 1997-12-17
FI950962L (fi) 1996-09-02
FI100556B (fi) 1997-12-31
NZ301725A (en) 2001-02-23
EP0812421B1 (de) 2002-06-19
ES2175069T3 (es) 2002-11-16
FI950962A0 (fi) 1995-03-01
DE69621915T2 (de) 2003-01-23
AU4721596A (en) 1996-09-18
WO1996027131A1 (en) 1996-09-06
DE69621915D1 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
HUP9902327A2 (hu) Humán gp39-elleni humanizált antitestek, az antitesteket tartalmazó készítmények és terápiás alkalmazásuk
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ATE199259T1 (de) Tie-2 ligande, verfahren zu ihrer herstellung, und ihre anwendungen
WO1996034953A3 (en) Cd16-ii variants
MY136224A (en) Monkey monoclonal antibodies specific to human b7.1 and/or b7.2,primatized forms thereof,pharmaceutical compos itions containing, and use thereof as immunosuppressants
HU9500673D0 (en) Novel rapamycin binding proteins and their diagnostic and therapeutic use
CA2082390A1 (en) Dna encoding human 5-ht1d receptors and uses thereof
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
NZ332311A (en) Use of autoantigen HC gp-39 and proteins structurally related thereto in immunotherapy of autoimmune diseases particularly rheumatoid arthritis
WO2003072598A3 (en) Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
EP0973794A4 (de) Netrinrezeptoren
ZA961628B (en) Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases
WO1998006841A3 (en) Two human nsp-like proteins
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
MXPA02005236A (es) Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
SE9002212D0 (sv) Igg binding protein
WO1999057241A3 (en) Myelin basic protein peptides and uses thereof
EP2128257A3 (de) Mutationen des parkin-gens, zusammensetzungen, verfahren und verwendungen
EP1039931A4 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
PL321890A1 (en) Variants human dnase i
EP1293570A3 (de) Verwendung des Aprataxin Gens zur Diagnose und Behandlung der früheinsetzenden Hinterstrangataxie (EAOH - early-onset spinocerebellar ataxia)
WO2002070560A3 (en) Nuclear hormone receptor ligand binding domain
WO2004005346A3 (en) Human nuclear hormone receptor